News Focus
News Focus
Followers 35
Posts 2231
Boards Moderated 0
Alias Born 10/18/2019

Re: Hopeforthefuture3 post# 730026

Sunday, 11/03/2024 3:33:13 PM

Sunday, November 03, 2024 3:33:13 PM

Post# of 818308
Another presentation on Musellafoundation by Mimivax a spinoff from Roswell Park in a phase 2b trial with 63 gbm patients had 27% survival at 5 years. Vaccine sounds a bit similar to nwbo's but not personalized but at this point good results
Ceo of company presenting. Seems like LP or Bosch should get on the show and talk on the nwbo phase3 results.
Survaxm is vaccine, for methylated median OS at 41 months
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News